This company listing is no longer active
EMRI Stock Overview
Emerald Real Estate Investment engages in the real estate business in Egypt.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Emerald Real Estate Investment Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ج.م1.58 |
52 Week High | ج.م2.85 |
52 Week Low | ج.م1.08 |
Beta | -0.35 |
1 Month Change | -1.87% |
3 Month Change | -6.79% |
1 Year Change | -26.59% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 73.69% |
Recent News & Updates
Recent updates
Shareholder Returns
EMRI | EG Real Estate | EG Market | |
---|---|---|---|
7D | 0% | 4.9% | 3.5% |
1Y | -26.6% | 235.9% | 89.2% |
Return vs Industry: EMRI underperformed the EG Real Estate industry which returned 1.9% over the past year.
Return vs Market: EMRI underperformed the EG Market which returned 8.7% over the past year.
Price Volatility
EMRI volatility | |
---|---|
EMRI Average Weekly Movement | 8.7% |
Real Estate Industry Average Movement | 9.0% |
Market Average Movement | 8.2% |
10% most volatile stocks in EG Market | 11.9% |
10% least volatile stocks in EG Market | 5.0% |
Stable Share Price: EMRI has not had significant price volatility in the past 3 months.
Volatility Over Time: EMRI's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of EG stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | n/a | Hashem Hashem Desouky | https://www.emerald-re.com |
Emerald Real Estate Investment engages in the real estate business in Egypt. It owns Emerald twin plaza, a commercial mall on the First Settlement- New Cairo. The company was founded in 2009 and is headquartered in Giza, Egypt.
Emerald Real Estate Investment Fundamentals Summary
EMRI fundamental statistics | |
---|---|
Market cap | ج.م434.23m |
Earnings (TTM) | ج.م29.46m |
Revenue (TTM) | ج.م67.71m |
14.7x
P/E Ratio6.4x
P/S RatioIs EMRI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EMRI income statement (TTM) | |
---|---|
Revenue | ج.م67.71m |
Cost of Revenue | ج.م15.10m |
Gross Profit | ج.م52.62m |
Other Expenses | ج.م23.16m |
Earnings | ج.م29.46m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.11 |
Gross Margin | 77.71% |
Net Profit Margin | 43.51% |
Debt/Equity Ratio | 7.1% |
How did EMRI perform over the long term?
See historical performance and comparison